Supplementary Fig 1 from Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR&lt;sup&gt;+&lt;/sup&gt;, HER2&lt;sup&gt;−&lt;/sup&gt; Advanced Breast Cancer